Skip to content
Clinical Trials – home
BulgariaBack to Bulgaria

Clinical trials in Veliko Tirnovo – page 5

78 clinical trials in Veliko Tirnovo, Bulgaria across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.

Veliko Tirnovo at a glance
78
clinical trials
  • Paediatric trials0
  • Research sites1
Type of trial
Recruitment status
Quick filters

78 trials in Veliko Tirnovo

Open in trial search

Arteriosclerosis

Not recruiting

Study of inclisiran to prevent heart attacks and strokes in people with atherosclerotic cardiovascular disease

Registered drug
Countries:BulgariaBulgaria
  • Participants:18–64 years · 65+ years
  • Substances:Atorvastatin
  • Sponsor:Novartis Pharma AG

Arteriosclerosis

Not recruiting

Study on the Effect of Obicetrapib in Patients with Atherosclerotic Cardiovascular Disease Not Adequately Managed by Current Lipid-Lowering Treatments

Investigational
Countries:BulgariaBulgaria
  • Participants:18–64 years · 65+ years
  • Substances:Obicetrapib
  • Sponsor:NewAmsterdam Pharma B.V.

Neuralgia

Not recruiting

Study on the Effectiveness and Safety of NT 201 Injections for Adults with Chronic Neuropathic Pain from Postherpetic Neuralgia or Nerve Injury

Registered drug
Countries:BulgariaBulgaria
  • Participants:18–64 years · 65+ years
  • Substances:Paracetamol
  • Sponsor:Merz Therapeutics GmbH

Hypertriglyceridaemia

Not recruiting

Study of ISIS 678354 for Patients with Severe Hypertriglyceridemia

InvestigationalNo placebo
Countries:BulgariaBulgaria
  • Participants:18–64 years · 65+ years
  • Substances:ISIS 678354 sodium salt
  • Sponsor:Ionis Pharmaceuticals Inc.

Study of Astegolimab Treatment in Patients with Chronic Obstructive Pulmonary Disease (COPD) to Reduce Disease Flare-ups

Investigational
Countries:BulgariaBulgaria
  • Participants:18–64 years · 65+ years
  • Substances:Astegolimab
  • Sponsor:F. Hoffmann-La Roche AG

Atrial fibrillation

Not recruiting

Study on Milvexian and Apixaban for Preventing Stroke in Patients with Atrial Fibrillation

Registered drug
Countries:BulgariaBulgaria
  • Participants:18–64 years · 65+ years
  • Substances:Andexanet Alfa
  • Sponsor:Janssen Cilag International

Arteriosclerosis

Not recruiting

Study on Inclisiran for Preventing Heart Disease in High-Risk Patients

Registered drug
Countries:BulgariaBulgaria
  • Participants:18–64 years · 65+ years
  • Substances:Inclisiran
  • Sponsor:Novartis Pharma AG

Hypertriglyceridaemia

Not recruiting

Study on the Effects of Pegozafermin and Simvastatin for Patients with Severe High Triglycerides

Registered drug
Countries:BulgariaBulgaria
  • Participants:18–64 years · 65+ years
  • Substances:BIO89-100
  • Sponsor:89bio Inc.

Obesity

Not recruiting

Weight loss in adults with obesity (with or without type 2 diabetes) using cagrilintide and semaglutide: a study of two dose levels versus semaglutide alone

InvestigationalNo placebo
Countries:BulgariaBulgaria
  • Participants:18–64 years · 65+ years
  • Substances:Cagrilintide
  • Sponsor:Novo Nordisk A/S

Study comparing subcutaneous versus intravenous ublituximab in patients with relapsing multiple sclerosis

InvestigationalNo placebo
Countries:BulgariaBulgaria
  • Participants:18–64 years
  • Substances:Ublituximab
  • Sponsor:Tg Therapeutics Inc.

Study of tozorakimab effectiveness and safety in former smokers with Chronic Obstructive Pulmonary Disease (COPD) who experience disease flare-ups

Registered drug
Countries:BulgariaBulgaria
  • Participants:18–64 years · 65+ years
  • Substances:Salbutamol
  • Sponsor:AstraZeneca AB

Study on the Effects of Itepekimab in Patients with Moderate-to-Severe Chronic Obstructive Pulmonary Disease (COPD)

Investigational
Countries:BulgariaBulgaria
  • Participants:18–64 years · 65+ years
  • Substances:Itepekimab
  • Sponsor:Sanofi-Aventis Recherche & Developpement

Other cities in Bulgaria

The busiest research cities in the country

All 53 cities in Bulgaria

Clinical research in Veliko Tirnovo

What the registry says about research in the country

01 Cardiovascular Research

Extensive studies focusing on atherosclerotic cardiovascular disease and innovative treatments for heart conditions. Research includes evaluation of new medications for reducing cardiovascular events and managing blood lipid levels.

  • Deep Vein Thrombosis Treatment
  • Stroke Prevention in Atrial Fibrillation
  • Heart Failure Management

Trials are investigating novel approaches to cholesterol management and prevention of major adverse cardiovascular events.

02 Respiratory Medicine

Advanced research into chronic obstructive pulmonary disease (COPD) treatments and respiratory infections. Studies evaluate new therapeutic combinations and treatment efficacy.

  • COPD Treatment Optimization
  • Respiratory Syncytial Virus Therapy
  • Lung Function Improvement

Focus on developing improved inhalation therapies and testing new drug formulations for respiratory conditions.

03 Gastroenterology Studies

Innovative research in treating ulcerative colitis and inflammatory bowel conditions. Multiple trials exploring combination therapies and long-term treatment options.

  • Moderate to Severe Ulcerative Colitis
  • Novel Treatment Combinations
  • Long-term Disease Management

Emphasis on developing sustainable treatment approaches for chronic gastrointestinal conditions.

04 Mental Health Research

Comprehensive studies on major depressive disorder and other psychiatric conditions. Investigation of new therapeutic approaches for mental health management.

  • Schizophrenia Treatment
  • Bipolar Disorder Management
  • Depression Therapy

Focus on long-term safety and efficacy of new psychiatric medications.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.